Sitavig Interactions
There are 67 drugs known to interact with Sitavig (acyclovir), along with 4 disease interactions. Of the total drug interactions, 25 are major, 34 are moderate, and 8 are minor.
- View all 67 medications that may interact with Sitavig
- View Sitavig disease interactions (4)
Most frequently checked interactions
View interaction reports for Sitavig (acyclovir) and the medicines listed below.
- acetaminophen / oxycodone
- Aczone (dapsone topical)
- adapalene topical
- Advair Diskus (fluticasone / salmeterol)
- Adzenys ER (amphetamine)
- Aklief (trifarotene topical)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- Alphagan P (brimonidine ophthalmic)
- Altabax (retapamulin topical)
- Altreno (tretinoin topical)
- amiloride
- ammonium lactate topical
- Amzeeq (minocycline topical)
- anastrozole
- aprepitant
- Aqua Glycolic (emollients topical)
- Aquaphor (emollients topical)
- Arava (leflunomide)
- Arazlo (tazarotene topical)
- aripiprazole
- Aspir 81 (aspirin)
- Atopiclair (emollients topical)
- Azulfidine (sulfasalazine)
- Benadryl (diphenhydramine)
- Bensal HP (salicylic acid topical)
- finasteride
- metformin
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Sitavig disease interactions
There are 4 disease interactions with Sitavig (acyclovir) which include:
More about Sitavig (acyclovir)
- Sitavig consumer information
- Compare alternatives
- Reviews (13)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: purine nucleosides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.